XOMAP
XOMA Royalty Corp
Key Financials
Operating Income
$11.4M
↑ 128.5%
Revenue
$52.1M
↑ 83.1%
Net Income
$31.7M
↑ 329.4%
Total Assets
$272.7M
↑ 23.2%
EPS (Diluted)
$1.46
↑ 188.5%
Total Liabilities
$168.7M
↑ 21.1%
Cash & Equivalents
$82.9M
↓ 18.4%
Long-term Debt
$96.5M
↓ 9.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XOMAP |
| Company Name | XOMA Royalty Corp |
| CIK | 791908 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 510-204-7239 |